We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Hitachi & Microsoft to Facilitate Business Process Automation
Read MoreHide Full Article
Hitachi Ltd. (HTHIY - Free Report) recently announced a partnership with Microsoft Corporation (MSFT - Free Report) to facilitate process automation of manufacturing facilities and boost efficiency in logistics operations.
Under the multi-year partnership, the companies will jointly work on offering three Hitachi solutions to customers across Japan, Southeast Asia and North America. Notably, the offerings include Hitachi’s solutions like manufacturing productivity, predictive maintenance and logistics optimization, powered by several Microsoft cloud services.
Hitachi will integrate its advanced digital solutions, Lumada, as well as HX Series industrial controllers with Microsoft Azure, Microsoft 365 and Dynamics 365 application suites to enable businesses enhance their workers’ operational productivity and efficiency.
Also, Hitachi’s advanced analytics will help business units realize higher logistics efficiency and cut operational costs by facilitating traffic, storage and delivery location analysis as well as smart routing with the help of Azure Maps and delivery optimization service. In addition, the predictive maintenance solution will leverage Microsoft HoloLens 2 and Dynamics 365 Remote Assist to support predictive maintenance and real-time remote assistance for front-line workers.
Zacks Rank, Price Performance and Estimate Trend
The company, with a $30.4-billion market capitalization, currently carries a Zacks Rank #5 (Strong Sell).
Over the past six months, the stock has lost 24.7% compared with the industry’s decline of 17.5%.
In the past 60 days, the Zacks Consensus Estimate for the company’s earnings has declined 21.3% to $10.88 for fiscal 2020 (ending March 2021).
Stocks to Consider
A couple of better-ranked stocks are Macquarie Infrastructure Company and Graphic Packaging Holding Company (GPK - Free Report) . While Macquarie currently sports a Zacks Rank #1 (Strong Buy), Graphic Packaging carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Macquarie has a positive earnings surprise of 3.13%, on average, for the trailing four quarters.
Graphic Packaging has a positive earnings surprise of 9.59%, on average, for the last four quarters.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Hitachi & Microsoft to Facilitate Business Process Automation
Hitachi Ltd. (HTHIY - Free Report) recently announced a partnership with Microsoft Corporation (MSFT - Free Report) to facilitate process automation of manufacturing facilities and boost efficiency in logistics operations.
Under the multi-year partnership, the companies will jointly work on offering three Hitachi solutions to customers across Japan, Southeast Asia and North America. Notably, the offerings include Hitachi’s solutions like manufacturing productivity, predictive maintenance and logistics optimization, powered by several Microsoft cloud services.
Hitachi will integrate its advanced digital solutions, Lumada, as well as HX Series industrial controllers with Microsoft Azure, Microsoft 365 and Dynamics 365 application suites to enable businesses enhance their workers’ operational productivity and efficiency.
Also, Hitachi’s advanced analytics will help business units realize higher logistics efficiency and cut operational costs by facilitating traffic, storage and delivery location analysis as well as smart routing with the help of Azure Maps and delivery optimization service. In addition, the predictive maintenance solution will leverage Microsoft HoloLens 2 and Dynamics 365 Remote Assist to support predictive maintenance and real-time remote assistance for front-line workers.
Zacks Rank, Price Performance and Estimate Trend
The company, with a $30.4-billion market capitalization, currently carries a Zacks Rank #5 (Strong Sell).
Over the past six months, the stock has lost 24.7% compared with the industry’s decline of 17.5%.
In the past 60 days, the Zacks Consensus Estimate for the company’s earnings has declined 21.3% to $10.88 for fiscal 2020 (ending March 2021).
Stocks to Consider
A couple of better-ranked stocks are Macquarie Infrastructure Company and Graphic Packaging Holding Company (GPK - Free Report) . While Macquarie currently sports a Zacks Rank #1 (Strong Buy), Graphic Packaging carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Macquarie has a positive earnings surprise of 3.13%, on average, for the trailing four quarters.
Graphic Packaging has a positive earnings surprise of 9.59%, on average, for the last four quarters.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>